Lai‐Ming Ching

2.5k total citations
77 papers, 2.1k citations indexed

About

Lai‐Ming Ching is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Lai‐Ming Ching has authored 77 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 28 papers in Molecular Biology and 27 papers in Immunology. Recurrent topics in Lai‐Ming Ching's work include Immune Cell Function and Interaction (13 papers), Cancer therapeutics and mechanisms (11 papers) and Cytokine Signaling Pathways and Interactions (11 papers). Lai‐Ming Ching is often cited by papers focused on Immune Cell Function and Interaction (13 papers), Cancer therapeutics and mechanisms (11 papers) and Cytokine Signaling Pathways and Interactions (11 papers). Lai‐Ming Ching collaborates with scholars based in New Zealand, United States and China. Lai‐Ming Ching's co-authors include Bruce C. Baguley, Philip Kestell, Martin Philpott, Baguley Bc, Brian D. Palmer, Lindy L. Thomsen, Bruce C. Baguley, J. Marbrook, Wayne R. Joseph and Jing Sun and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Lai‐Ming Ching

77 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lai‐Ming Ching New Zealand	24	1.0k	728	542	381	174	77	2.1k
Dona Alberti United States	30	1.4k 1.3×	317 0.4×	1.0k 1.9×	387 1.0×	101 0.6×	90	2.8k
Khandaker Siddiquee United States	12	1.1k 1.1×	301 0.4×	874 1.6×	199 0.5×	228 1.3×	27	2.1k
Scott J. Weir United States	29	928 0.9×	187 0.3×	560 1.0×	301 0.8×	191 1.1×	106	2.2k
Chung-Wai Shiau Taiwan	37	2.1k 2.1×	374 0.5×	957 1.8×	560 1.5×	236 1.4×	68	3.4k
Sukh Mahendra Singh India	27	886 0.9×	670 0.9×	456 0.8×	515 1.4×	95 0.5×	114	2.1k
Tomoko Oh‐hara Japan	31	2.0k 1.9×	182 0.3×	1.7k 3.2×	364 1.0×	178 1.0×	65	3.4k
Karuppaiyah Selvendiran United States	35	1.8k 1.8×	268 0.4×	687 1.3×	854 2.2×	136 0.8×	67	3.1k
George G. Chen Hong Kong	31	2.2k 2.2×	397 0.5×	862 1.6×	1.1k 2.9×	233 1.3×	119	3.6k
Vladimir Kolenko United States	30	1.4k 1.3×	560 0.8×	720 1.3×	620 1.6×	112 0.6×	63	2.7k

Countries citing papers authored by Lai‐Ming Ching

Since Specialization

Citations

This map shows the geographic impact of Lai‐Ming Ching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lai‐Ming Ching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lai‐Ming Ching more than expected).

Fields of papers citing papers by Lai‐Ming Ching

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lai‐Ming Ching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lai‐Ming Ching. The network helps show where Lai‐Ming Ching may publish in the future.

Co-authorship network of co-authors of Lai‐Ming Ching

This figure shows the co-authorship network connecting the top 25 collaborators of Lai‐Ming Ching. A scholar is included among the top collaborators of Lai‐Ming Ching based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lai‐Ming Ching. Lai‐Ming Ching is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tomek, Petr, Cristin G. Print, Michael A. Black, et al.. (2018). Imprinted and ancient gene: a potential mediator of cancer cell survival during tryptophan deprivation. Cell Communication and Signaling. 16(1). 88–88. 3 indexed citations

Tomek, Petr, Brian D. Palmer, Jackie D. Kendall, Jack U. Flanagan, & Lai‐Ming Ching. (2015). Formation of fluorophores from the kynurenine pathway metabolite N-formylkynurenine and cyclic amines involves transamidation and carbon–carbon bond formation at the 2-position of the amine. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(9). 1772–1780. 7 indexed citations

Zhang, Jie, Simon J. O’Carroll, Kimiora Henare, et al.. (2014). Connexin hemichannel induced vascular leak suggests a new paradigm for cancer therapy. FEBS Letters. 588(8). 1365–1371. 23 indexed citations

Sun, Jing, Liang‐Chuan S. Wang, Zvi G. Fridlender, et al.. (2011). Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation. Biochemical Pharmacology. 82(9). 1175–1185. 14 indexed citations

Wang, Liang‐Chuan S., Lotte Thomsen, R. M. Sutherland, et al.. (2009). Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404). Neoplasia. 11(8). 793–803. 39 indexed citations

Chen, Qingyun, Daniel Jones, Peter Stone, Lai‐Ming Ching, & Larry Chamley. (2008). Vitamin C Enhances Phagocytosis of Necrotic Trophoblasts by Endothelial Cells and Protects the Phagocytosing Endothelial Cells from Activation. Placenta. 30(2). 163–168. 7 indexed citations

Roberts, Zachary, Lai‐Ming Ching, & Stefanie N. Vogel. (2008). IFN- β -Dependent Inhibition of Tumor Growth by the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA). Journal of Interferon & Cytokine Research. 28(3). 133–139. 27 indexed citations

Roberts, Zachary, Nadège Goutagny, Pin‐Yu Perera, et al.. (2007). The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis. The Journal of Experimental Medicine. 204(7). 1559–1569. 127 indexed citations

Kestell, Philip, Bruce C. Baguley, Brian D. Palmer, et al.. (2002). Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomide. Cancer Chemotherapy and Pharmacology. 50(3). 186–192. 17 indexed citations

10.

Kestell, Philip, et al.. (2002). Oral activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice. Cancer Chemotherapy and Pharmacology. 49(1). 20–26. 17 indexed citations

11.

Zhou, Shu‐Feng, Philip Kestell, Malcolm D. Tingle, Lai‐Ming Ching, & James W. Paxton. (2001). A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide. Cancer Chemotherapy and Pharmacology. 47(6). 541–544. 8 indexed citations

12.

Philpott, Martin, Lai‐Ming Ching, & Bruce C. Baguley. (2001). The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor. European Journal of Cancer. 37(15). 1930–1937. 39 indexed citations

13.

Philpott, Martin, Bruce C. Baguley, & Lai‐Ming Ching. (1995). Induction of tumour necrosis factor-? by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Chemotherapy and Pharmacology. 36(2). 143–148. 99 indexed citations

14.

Ching, Lai‐Ming, Wayne R. Joseph, Li Zhuang, & Bruce C. Baguley. (1994). Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours. Cancer Chemotherapy and Pharmacology. 35(2). 153–160. 12 indexed citations

15.

Thomsen, Lindy L., Lai‐Ming Ching, Wayne R. Joseph, Bruce C. Baguley, & J.B. Gavin. (1992). Nitric oxide production in endotoxin-resistant C3H/HeJ mice stimulated with flavone-8-acetic acid and xanthenone-4-acetic acid analogues. Biochemical Pharmacology. 43(11). 2401–2406. 14 indexed citations

16.

Ching, Lai‐Ming, Mark J. McKeage, Wayne R. Joseph, et al.. (1991). Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-methyl-xanthenone-4-acetic acid and flavone acetic acid. Cancer Chemotherapy and Pharmacology. 28(6). 414–419. 7 indexed citations

17.

Ching, Lai‐Ming, Graeme J. Finlay, Wayne R. Joseph, & Bruce C. Baguley. (1990). Comparison of the cytotoxicity of amsacrine and its analogue CI-921 against cultured human and mouse bone marrow tumour cells. European Journal of Cancer and Clinical Oncology. 26(1). 49–54. 6 indexed citations

18.

Ching, Lai‐Ming & Bruce C. Baguley. (1989). Reduction of cytotoxic effector cell activity in colon 38 tumours following treatment with flavone acetic acid. European Journal of Cancer and Clinical Oncology. 25(7). 1061–1065. 8 indexed citations

19.

Ching, Lai‐Ming & Bruce C. Baguley. (1988). Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512). European Journal of Cancer and Clinical Oncology. 24(9). 1521–1525. 42 indexed citations

20.

Schneider, Erasmus, et al.. (1988). Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II. European Journal of Cancer and Clinical Oncology. 24(11). 1783–1790. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact